EPS

QuinStreet's major acquisition of HomeBuddy aims to reshape the digital home services market by combining scale with exclusive, high-intent contractor leads.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

Facing a 79% stock plunge, automotive tech firm MKDWELL repurchases shares worth 77% of its market cap in a bold display of confidence.

The Baldwin Group finalizes its mega-merger with CAC Group, creating a new powerhouse with over $2B in projected revenue and deep specialty expertise.

The AI defense firm is cleaning its balance sheet by converting debt to stock, a move that strengthens its finances but dilutes existing shareholders.

The planned exit of a key technology leader sends ripples through Photronics, raising questions about its innovation roadmap despite record financial success.

Interactive Brokers reports its clients beat the S&P 500 in 2025. We dive into the numbers, the platform's unique advantages, and what this means for you.

As Calix announces its Q4 earnings date and a major Investor Day, all eyes are on its agentic AI platform and strategy to redefine broadband services.

Investors eye Hexcel's Q4 2025 results for signs of an aerospace rebound, strategic shifts under new leadership, and the future of advanced composites.

HVAC/R giant Watsco extends its 52-year dividend streak, signaling robust financial health and a strategy built on market consolidation and AI.

Smart cart maker A2Z Cust2Mate pivots for hyper-growth as its visionary founder exits, leaving the CEO as interim chair to steer a global expansion strategy.

Investors await Polaris's Q4 results on Jan. 27, seeking clarity on market share gains, tariff impacts, and the future of its Indian Motorcycle brand.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

As Axos sets to reveal its Q2 results, investors weigh strong growth forecasts against mounting concerns over margin pressure and a shifting economy.

Veracyte prepares for the J.P. Morgan conference, where it will showcase its AI and genomic strategy amid strong financials and a competitive market.

As CooperCompanies heads to the J.P. Morgan conference, all eyes are on CEO Al White's strategic vision for its dual vision and women's health units.

As Northern Trust prepares its Q4 2025 earnings call, investors seek clues on its resilience amid shifting economic tides and strategic digital pivots.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.